AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34193208 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocyte distribution width (MDW)
Number of subjects: 1517
Study 34193208 — intervention group
Group type: EXPERIMENTAL
Intervention: MDW combined with WBC
Number of subjects: 1517
Study 34193208 — intervention group
Group type: COMPARATOR
Intervention: C-reactive protein (CRP)
Number of subjects: 1517
Study 34193208 — intervention group
Group type: COMPARATOR
Intervention: Procalcitonin (PCT)
Number of subjects: 1517
Study 34193208 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal MDW
Number of subjects: 1517
Study 34193214 — intervention group
Group type: EXPERIMENTAL
Intervention: Concordant 1 couples (70.3% agreed women were involved)
Number of subjects: 961
Study 34193214 — intervention group
Group type: COMPARATOR
Intervention: Discordant 2 couples (12.2% had women report uninvolvement but men report involvement)
Number of subjects: 961
Study 34193433 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor environmental exposures
Number of subjects: 240
Study 34193433 — intervention group
Group type: EXPERIMENTAL
Intervention: Measures of indoor air quality constituents
Number of subjects: 240
Study 34193488 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-related discussions initiated by healthcare professionals (HCPs)
Number of subjects: 1500
Study 34193488 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-related discussions initiated by people with obesity (PwO)
Number of subjects: 1500
Study 34193488 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptions of responsibility for weight loss
Number of subjects: 1500
Study 34193488 — intervention group
Group type: EXPERIMENTAL
Intervention: Criteria for initiating weight management conversations
Number of subjects: 1500
Study 34193488 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for not discussing weight by HCPs
Number of subjects: 1500
Study 34193488 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient preferences for weight discussions
Number of subjects: 1500
Study 34193488 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional responses of PwO after weight discussions
Number of subjects: 1500
Study 34193488 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up appointments after weight discussions
Number of subjects: 1500
Study 34193595 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer drugs targeting novel blood glucose-lowering pathways
Number of subjects: 0
Study 34193595 — intervention group
Group type: COMPARATOR
Intervention: Traditional pharmacologic therapies (insulin, metformin, sulfonylureas)
Number of subjects: 0
Study 34193595 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatments targeting incretin action, islet transplantation, generation of functional beta cells from stem cells
Number of subjects: 0
Study 34194387 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive assessment using retinal vessel analysis
Number of subjects: 0
Study 34194396 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Surveillance (AS)
Number of subjects: 0
Study 34194396 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 0
Study 34194586 — intervention group
Group type: EXPERIMENTAL
Intervention: Arousal predominant group
Number of subjects: 577
Study 34194586 — intervention group
Group type: COMPARATOR
Intervention: Nonarousal predominant group
Number of subjects: 577
Study 34194721 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (L-T4) therapy for 12 months
Number of subjects: 37
Study 34195237 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-weight fluctuation
Number of subjects: 0
Study 34195237 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34195252 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobronchial administration of autologous bone marrow mesenchymal stromal cells (BM-MSCs)
Number of subjects: 13
Study 34195402 — intervention group
Group type: EXPERIMENTAL
Intervention: Arteek-SP
Number of subjects: 179
Study 34195402 — intervention group
Group type: COMPARATOR
Intervention: Septanest
Number of subjects: 179
Study 34195471 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative preparation with Lugol's Solution (LS)
Number of subjects: 270
Study 34195471 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative preparation with LS)
Number of subjects: 270
Study 34195486 — intervention group
Group type: EXPERIMENTAL
Intervention: Lattice SBRT
Number of subjects: 11
Study 34195525 — intervention group
Group type: EXPERIMENTAL
Intervention: PRKAR1B p.R115K variant
Number of subjects: 457
Study 34195525 — intervention group
Group type: COMPARATOR
Intervention: Wildtype PRKAR1B
Number of subjects: 457
Study 34195575 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% aqueous CHG
Number of subjects: 80
Study 34195575 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% CHG plus emollient
Number of subjects: 80
Study 34195575 — intervention group
Group type: EXPERIMENTAL
Intervention: Emollient only
Number of subjects: 80
Study 34195575 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC: no antiseptic/emollient)
Number of subjects: 80
Study 34195683 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteomics analysis of sentinel lymph nodes (SLN) from individuals with endometrial cancer (EC)
Number of subjects: 0
Study 34195794 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular weight heparin (LMWH) and/or low-dose aspirin (ASA)
Number of subjects: 265
Study 34195794 — intervention group
Group type: COMPARATOR
Intervention: No treatment (absence of LMWH/ASA)
Number of subjects: 265
Study 34195794 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH (with or without ASA)
Number of subjects: 265
Study 34195794 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH prophylaxis (alone or in association with ASA)
Number of subjects: 265
Study 34195803 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-cTnT-Elecsys
Number of subjects: 5887
Study 34195803 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-cTnI-Architect
Number of subjects: 5887
Study 34196037 — intervention group
Group type: EXPERIMENTAL
Intervention: Entospletinib in combination with obinutuzumab
Number of subjects: 17
Study 34196165 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafasitamab (12 mg/kg intravenously) plus Lenalidomide (25 mg orally)
Number of subjects: 80
Study 34196381 — intervention group
Group type: EXPERIMENTAL
Intervention: TR3 technique
Number of subjects: 8
Study 34196676 — intervention group
Group type: EXPERIMENTAL
Intervention: Betibeglogene autotemcel (beti-cel) gene therapy
Number of subjects: 1
Study 34196676 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy
Number of subjects: 1
Study 34196963 — intervention group
Group type: COMPARATOR
Intervention: Visual interventions
Number of subjects: 1951
Study 34196963 — intervention group
Group type: COMPARATOR
Intervention: Prism adaptation
Number of subjects: 1951
Study 34196963 — intervention group
Group type: COMPARATOR
Intervention: Body awareness interventions
Number of subjects: 1951
Study 34196963 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive brain stimulation (NIBS)
Number of subjects: 1951
Study 34196963 — intervention group
Group type: COMPARATOR
Intervention: Mental function interventions
Number of subjects: 1951
Study 34196963 — intervention group
Group type: COMPARATOR
Intervention: Movement interventions
Number of subjects: 1951
Study 34196963 — intervention group
Group type: COMPARATOR
Intervention: Electrical stimulation
Number of subjects: 1951
Study 34196963 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 1951
Study 34196991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultralow temperature cryoablation using near-critical nitrogen
Number of subjects: 30
Study 34197151 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 34197184 — intervention group
Group type: EXPERIMENTAL
Intervention: High-altitude environment
Number of subjects: 0
Study 34197212 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide (N = 21)
Number of subjects: 99
Study 34197212 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone (N = 27)
Number of subjects: 99
Study 34197356 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadopiclenol (0.1 mmol/kg)
Number of subjects: 40
Study 34198246 — intervention group
Group type: EXPERIMENTAL
Intervention: MT+IVT
Number of subjects: 2895
Study 34198246 — intervention group
Group type: COMPARATOR
Intervention: MT
Number of subjects: 2895
Study 34198338 — intervention group
Group type: EXPERIMENTAL
Intervention: Early postoperative atrial fibrillation (POAF) detected in 27 patients (34%)
Number of subjects: 79
Study 34198338 — intervention group
Group type: EXPERIMENTAL
Intervention: Late POAF episodes
Number of subjects: 79
Study 34198338 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically induced AF in POAF patients
Number of subjects: 79
Study 34198338 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of late POAF
Number of subjects: 79
Study 34198338 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with early POAF, higher age, larger RA, or prolonged PR time
Number of subjects: 79
Study 34199550 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet
Number of subjects: 80
Study 34199550 — intervention group
Group type: COMPARATOR
Intervention: Non-vegan diet
Number of subjects: 80
Study 34199925 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial allergen challenge in AA patients
Number of subjects: 38
Study 34199925 — intervention group
Group type: EXPERIMENTAL
Intervention: Eosinophils from SNEA patients
Number of subjects: 38
Study 34199925 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (HS)
Number of subjects: 38
Study 34200102 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein intake in TT-genotype carriers
Number of subjects: 810
Study 34200140 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 100
Study 34200805 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised exercise group programme + app with motivational messages
Number of subjects: 172
Study 34200805 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised exercise group programme + app with no motivational messages
Number of subjects: 172
Study 34200805 — intervention group
Group type: COMPARATOR
Intervention: Control group (app with no motivational messages)
Number of subjects: 172
Study 34201045 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-learning algorithm for detecting and classifying choroidal neovascularization (CNV) on spectral-domain optical coherence tomography (SD-OCT) images.
Number of subjects: 1568
Study 34201045 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-learning algorithm for classifying CNV types on SD-OCT images.
Number of subjects: 1568
Study 34201045 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-learning algorithm for discriminating CNV types on baseline SD-OCT images.
Number of subjects: 1568
Study 34201045 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-learning algorithm for detecting CNV presence and subtypes on SD-OCT images.
Number of subjects: 1568
Study 34201380 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted osmotic lysis
Number of subjects: 1
Study 34201806 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral melatonin (1 mg) plus zinc (10 mg) supplementation
Number of subjects: 50
Study 34201806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 34203151 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting exhaled hydrogen (H2) levels
Number of subjects: 424
Study 34204604 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific Bioelectrical Impedance Vector Analysis (BIVA)
Number of subjects: 94
Study 34204604 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention program
Number of subjects: 94
Study 34204604 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 94
Study 34205056 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental socks with a central discharge element
Number of subjects: 38
Study 34205056 — intervention group
Group type: COMPARATOR
Intervention: Control socks (same design, weight, and fiber without the cushioning element)
Number of subjects: 38
Study 34205056 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental socks
Number of subjects: 38
Study 34205106 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34205457 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stability exercises (CSE)
Number of subjects: 0
Study 34205457 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study 34205575 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase Angle (PhA)
Number of subjects: 94
Study 34205660 — intervention group
Group type: EXPERIMENTAL
Intervention: Early collaborative intervention focusing on parent-infant interaction
Number of subjects: 0
Study 34205660 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34206149 — intervention group
Group type: EXPERIMENTAL
Intervention: DTF-QoL
Number of subjects: 0
Study 34206149 — intervention group
Group type: EXPERIMENTAL
Intervention: EORTC QOL-C30
Number of subjects: 0
Study 34206149 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 0
Study 34206446 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-centered practices (i.e., body scan and Hatha yoga practices)
Number of subjects: 104
Study 34206446 — intervention group
Group type: EXPERIMENTAL
Intervention: Informal practice
Number of subjects: 104
Study 34206446 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-centered practices (i.e., classical meditation)
Number of subjects: 104
Study 34206446 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness-based interventions
Number of subjects: 104
Study 34206826 — intervention group
Group type: EXPERIMENTAL
Intervention: Cantrixil (TRX-E-002-1); specific dosage and duration not mentioned.
Number of subjects: 0
Study 34206975 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial Scratching (ES) in group A1 (105 patients)
Number of subjects: 352
Study 34206975 — intervention group
Group type: COMPARATOR
Intervention: No Endometrial Scratching in group B1 (104 patients)
Number of subjects: 352
Study 34206975 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial Scratching (ES) in group A2 (71 patients)
Number of subjects: 352
Study 34206975 — intervention group
Group type: COMPARATOR
Intervention: No Endometrial Scratching in group B2 (72 patients)
Number of subjects: 352
Study 34208053 — intervention group
Group type: EXPERIMENTAL
Intervention: One-on-one coaching in natural environments following a workshop
Number of subjects: 0
Study 34208053 — intervention group
Group type: COMPARATOR
Intervention: Training workshop
Number of subjects: 0
Study 34208271 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise test (CPET)
Number of subjects: 70
Study 34208271 — intervention group
Group type: EXPERIMENTAL
Intervention: Transthoracic echocardiogram
Number of subjects: 70
Study 34208271 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary lung test
Number of subjects: 70
Study 34208271 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-minute walking test
Number of subjects: 70
Study 34208271 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum biomarker analysis
Number of subjects: 70
Study 34208271 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life questionnaires
Number of subjects: 70
Study 34208432 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term therapy with Statins and Acetyl Salicylic Acid
Number of subjects: 0
Study 34208432 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34208859 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates Method
Number of subjects: 72
Study 34208859 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study 34209562 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant/Salvage Radiotherapy (ART/SRT)
Number of subjects: 408
Study 34210243 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet transfusion
Number of subjects: 0
Study 34210261 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored training and support (T&S) program for GPs with community mobilisation in municipality 1
Number of subjects: 3
Study 34210261 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored training and support (T&S) program for GPs without community mobilisation in municipality 2
Number of subjects: 3
Study 34210261 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention to facilitate data collection in municipality 3
Number of subjects: 3
Study 34210281 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted-CCI 4D-cycle caries care with non-aerosol generating procedures (non-AGP) and reduced in-office appointments' time
Number of subjects: 258
Study 34210341 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive Remediation Therapy (MCR)
Number of subjects: 66
Study 34210341 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized Cognitive Remediation (CCR)
Number of subjects: 66
Study 34210341 — intervention group
Group type: COMPARATOR
Intervention: No cognitive-enhancing intervention
Number of subjects: 66
Study 34210358 — intervention group
Group type: EXPERIMENTAL
Intervention: CFS score treated as categorical variable
Number of subjects: 7487
Study 34210358 — intervention group
Group type: EXPERIMENTAL
Intervention: CFS score treated as continuous variable
Number of subjects: 7487
Study 34210358 — intervention group
Group type: EXPERIMENTAL
Intervention: CFS score treated as dichotomous variable
Number of subjects: 7487
Study 34210358 — intervention group
Group type: EXPERIMENTAL
Intervention: CFS score relationship with mortality
Number of subjects: 7487
Study 34210826 — intervention group
Group type: EXPERIMENTAL
Intervention: SENTI-101 (a preparation of bone marrow-derived mesenchymal stromal cells engineered to express IL12 and IL21)
Number of subjects: 0
Study 34210826 — intervention group
Group type: EXPERIMENTAL
Intervention: mSENTI-101 (murine surrogate of SENTI-101)
Number of subjects: 0
Study 34210826 — intervention group
Group type: EXPERIMENTAL
Intervention: mSENTI-101 co-administered with checkpoint inhibitors
Number of subjects: 0
Study 34210826 — intervention group
Group type: COMPARATOR
Intervention: Recombinant cytokines (as a comparison)
Number of subjects: 0
Study 34211280 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologics
Number of subjects: 1109
Study 34211280 — intervention group
Group type: COMPARATOR
Intervention: Maintenance systemic corticosteroids (mSCS)
Number of subjects: 1109
Study 34211280 — intervention group
Group type: COMPARATOR
Intervention: High-dosage inhaled corticosteroids with additional controllers (HD ICS+)
Number of subjects: 1109
Study 34211773 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT 30 to 50 Gy in 5 fractions (median dose 40 Gy)
Number of subjects: 26
Study 34212125 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low-Calorie Diet (VLCD)
Number of subjects: 18
Study 34212188 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-sectional adrenal imaging
Number of subjects: 1311
Study 34212280 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation with low fluoroscopy
Number of subjects: 1243
Study 34212308 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position before spinal anesthesia (SA)
Number of subjects: 20
Study 34212308 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilted 15° position before spinal anesthesia (SA)
Number of subjects: 20
Study 34212308 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position after spinal anesthesia (SA)
Number of subjects: 20
Study 34212308 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilted 15° position after spinal anesthesia (SA)
Number of subjects: 20
Study 34212476 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-acting antiviral (DAA) therapy
Number of subjects: 775
Study 34212814 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed diagnosis, assessments and referrals
Number of subjects: 132
Study 34212814 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancellations of appointments, hospitalisations or procedures
Number of subjects: 132
Study 34212814 — intervention group
Group type: EXPERIMENTAL
Intervention: Home confinement-related incidents
Number of subjects: 132
Study 34212814 — intervention group
Group type: EXPERIMENTAL
Intervention: Inappropriate medication stopping
Number of subjects: 132
Study 34212814 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients delayed attending or did not consult their GP due to fear of COVID-19 infection
Number of subjects: 132
Study 34212814 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients did not consult their GP due to fear of burdening GPs
Number of subjects: 132
Study 34212836 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement of dietary intakes from medium quality to very low quality
Number of subjects: 0
Study 34212836 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement of dietary intakes from medium quality to very high quality
Number of subjects: 0
Study 34213298 — intervention group
Group type: COMPARATOR
Intervention: District hospitals
Number of subjects: 2983
Study 34213298 — intervention group
Group type: EXPERIMENTAL
Intervention: Academic hospitals
Number of subjects: 2983
Study 34213592 — intervention group
Group type: EXPERIMENTAL
Intervention: IV panitumumab
Number of subjects: 700
Study 34213636 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant capecitabine
Number of subjects: 0
Study 34213636 — intervention group
Group type: EXPERIMENTAL
Intervention: Ado-trastuzumab-emtansine (T-DM1)
Number of subjects: 0
Study 34213636 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathologic complete response (pCR)
Number of subjects: 0
Study 34213636 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing trials testing safety of omitting post-mastectomy breast and post-lumpectomy nodal irradiation
Number of subjects: 0
Study 34213636 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing trials testing safety of omitting axillary lymph node dissection
Number of subjects: 0
Study 34213636 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal residual disease (MRD) monitoring
Number of subjects: 0
Study 34213732 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg lipegfilgrastim (single SC injection)
Number of subjects: 24
Study 34213740 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) examination
Number of subjects: 203